BerandaBMRN • NASDAQ
add
Biomarin Pharmaceutical Inc
$67,07
Setelah Jam Perdagangan Normal:(0,10%)-0,070
$67,00
Tutup: 8 Nov, 17.46.06 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$66,94
Rentang hari
$66,67 - $67,44
Rentang tahun
$65,35 - $99,56
Kapitalisasi pasar
12,78 M USD
Volume Rata-Rata
1,42 jt
Rasio P/E
40,34
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 745,74 jt | 28,28% |
Biaya operasional | 443,39 jt | 4,88% |
Laba bersih | 106,08 jt | 162,72% |
Margin laba bersih | 14,22 | 104,60% |
Penghasilan per saham | 0,91 | 97,83% |
EBITDA | 132,90 jt | 136,43% |
Tarif pajak efektif | 21,10% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 930,44 jt | -17,36% |
Total aset | 6,85 M | 1,38% |
Total liabilitas | 1,44 M | -22,75% |
Total ekuitas | 5,41 M | — |
Saham yang beredar | 190,58 jt | — |
Harga terhadap nilai buku | 2,36 | — |
Tingkat pengembalian aset | 4,09% | — |
Tingkat pengembalian modal | 4,59% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 106,08 jt | 162,72% |
Kas dari operasi | 221,48 jt | 63,28% |
Kas dari investasi | -16,16 jt | 64,72% |
Kas dari pembiayaan | -499,12 jt | -63.240,74% |
Perubahan kas bersih | -296,70 jt | -425,93% |
Arus kas bebas | 165,57 jt | 86,81% |
Tentang
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria.
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Didirikan
Mar 1997
Kantor pusat
Situs
Karyawan
3.401
